INITIAL PHARMACOTHERAPY FOR OVERACTIVE BLADDER SYMPTOMS AMONG MEDICARE BENEFICIARIES

被引：0
|
作者：
Scales, Charles, Jr.
Greiner, Melissa
Curtis, Lesley
Hammill, Brad
Peterson, Andrew
Amundsen, Cindy
Martinez-Bianchi, Viviana
Heflin, Mitchell
Schmader, Kenneth
机构：
来源：
JOURNAL OF UROLOGY | 2016年 / 195卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP25-15
引用
收藏
页码：E285 / E285
页数：1
相关论文
共 50 条
  • [1] Prescribing Patterns for Overactive Bladder Symptoms Among Medicare Beneficiaries
    Scales, C.
    Greiner, M.
    Curtis, L.
    Hammill, B.
    Peterson, D.
    Heflin, M.
    Schmader, K.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2016, 64 : S118 - S118
  • [2] VARIATION IN CARE INTENSITY FOR OVERACTIVE BLADDER SYMPTOMS AMONG MEDICARE BENEFICIARIES
    Scales, Charles, Jr.
    Greiner, Melissa
    Curtis, Lesley
    Hammill, Brad
    Peterson, Andrew
    Amundsen, Cindy
    Schmader, Kenneth
    JOURNAL OF UROLOGY, 2017, 197 (04): : E926 - E926
  • [3] Variation in Care Intensity for Overactive Bladder Symptoms Among Medicare Beneficiaries
    Scales, C.
    Greiner, M.
    Curtis, L.
    Hammill, B.
    Peterson, D.
    Amundsen, C.
    Heflin, M.
    Schmader, K.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2017, 65 : S189 - S189
  • [4] Physician Use of Sacral Neuromodulation Among Medicare Beneficiaries With Overactive Bladder and Urinary Retention
    Suskind, Anne M.
    Clemens, J. Quentin
    Zhang, Yun
    Hollenbeck, Brent K.
    UROLOGY, 2015, 86 (01) : 30 - 34
  • [5] Antimuscarinic use among older adults with dementia and overactive bladder: a Medicare beneficiaries study
    Kachru, Nandita
    Holmes, Holly M.
    Johnson, Michael L.
    Chen, Hua
    Aparasu, Rajender R.
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (08) : 1303 - 1313
  • [6] Pharmacotherapy for detrusor instability and symptoms of the overactive bladder
    Chapple, C
    Jonas, U
    WORLD JOURNAL OF UROLOGY, 2001, 19 (05) : 293 - 293
  • [7] Pharmacotherapy for detrusor instability and symptoms of the overactive bladder
    Christopher Chapple
    Udo Jonas
    World Journal of Urology, 2001, 19 : 293 - 293
  • [8] Estimating the prevalence and economic burden of overactive bladder among Medicare beneficiaries prior to Medicare Part D coverage
    Cisternas, Miriam G.
    Foreman, Aimee J.
    Marshall, Thomas S.
    Runken, M. Chris
    Kobashi, Kathleen C.
    Seifeldin, Raafat
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (04) : 911 - 919
  • [9] MEDICATION SWITCHING AFTER INITIAL PHARMACOTHERAPY FOR OVERACTIVE BLADDER
    Scales, Charles, Jr.
    Greiner, Melissa
    Curtis, Lesley
    Hammill, Brad
    Peterson, Andrew
    Amundsen, Cindy
    Martinez-Bianchi, Viviana
    Heflin, Mitchell
    Schmader, Kenneth
    JOURNAL OF UROLOGY, 2016, 195 (04): : E285 - E285
  • [10] Frailty, Specialized Care, and Sociodemographic Factors: Disparities in Oral Pharmacotherapy Class Utilization Among Medicare Part D Beneficiaries With Overactive Bladder in the United States
    Enemchukwu, Ekene A.
    Sinclair, Shada
    Mohamud, Hodan
    Zhang, Chiyuan A.
    Anger, Jennifer T.
    Scales Jr, Charles D.
    UROLOGY, 2024, 191 : 49 - 56
12345